Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Albiana Pino, Annamaria Vaccaro & Giuseppe Sandro Mela. (2004) Triptans in migraine. A review of side effects, improvement and recurrence. The Pain Clinic 16:2, pages 115-129.
Read now
Read now
Alan M Rapoport, Marcelo E Bigal, Stewart J Tepper & Fred D Sheftell. (2004) Zolmitriptan (Zomig®). Expert Review of Neurotherapeutics 4:1, pages 33-41.
Read now
Read now
Bruce Charlesworth & Andrew J Dowson. (2002) Review of zolmitriptan and its clinical applications in migraine. Expert Opinion on Pharmacotherapy 3:7, pages 993-1005.
Read now
Read now
Alexander Mauskop, Markus Farkkila, Rachel Hering-Hanit, Alan Rapopot & John Warner. (1999) Zolmitriptan is Effective for the Treatment of Persistent and Recurrent Migraine Headache. Current Medical Research and Opinion 15:4, pages 282-289.
Read now
Read now
Michael Tuchman, Larrs Edvinsson, Gilles Geraud, Amos Korczyn, Alexander Mauskop & Volker Pfaffenrath. (1999) Zolmitriptan Provides Consistent Migraine Relief when Used in the Long Term. Current Medical Research and Opinion 15:4, pages 272-281.
Read now
Read now
Articles from other publishers (41)
Mario Fernando Prieto Peres, Wanessa Alessandra Ruiz Scala & Ricardo Salazar. (2022) Comparison between metamizole and triptans for migraine treatment: a systematic review and network meta-analysis. Headache Medicine 12:3, pages 182-230.
Crossref
Crossref
Peer Tfelt-Hansen, Karsten Jørgensen & Hans-Christoph Diener. (2021) Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacks. Cephalalgia 42:1, pages 82-85.
Crossref
Crossref
Jennifer Wu, Pranamya Suri, Danielle Perret Karimi & Bi-Ying Yeh. 2021. Migraine. Migraine
29
49
.
Jonathan Jia Yuan Ong & Milena De Felice. (2017) Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action. Neurotherapeutics 15:2, pages 274-290.
Crossref
Crossref
Haiyang Xu, Wei Han, Jinghua Wang & Mingxian Li. (2016) Network meta-analysis of migraine disorder treatment by NSAIDs and triptans. The Journal of Headache and Pain 17:1.
Crossref
Crossref
Peer Tfelt-HansenStine F. Jespersen. (2016) The Evidence for Prescription Information for Possible Use of a Repeated Dose of Oral Triptans: A Comment. Headache: The Journal of Head and Face Pain 56:5, pages 878-882.
Crossref
Crossref
Lars Edvinsson. 2016. Pharmacological Management of Headaches. Pharmacological Management of Headaches
53
62
.
Werner J. Becker. (2015) Acute Migraine Treatment. CONTINUUM: Lifelong Learning in Neurology 21, pages 953-972.
Crossref
Crossref
Werner J. Becker. (2015) Acute Migraine Treatment in Adults. Headache: The Journal of Head and Face Pain 55:6, pages 778-793.
Crossref
Crossref
Sarah Bird, Sheena Derry & R Andrew Moore. (2014) Zolmitriptan for acute migraine attacks in adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Mark J. Niciu, Daniel C. Mathews, Allison C. Nugent, Dawn F. Ionescu, Maura L. Furey, Erica M. Richards, Rodrigo Machado-Vieira & Carlos A. ZarateJr.Jr.. (2014) DEVELOPING BIOMARKERS IN MOOD DISORDERS RESEARCH THROUGH THE USE OF RAPID-ACTING ANTIDEPRESSANTS. Depression and Anxiety 31:4, pages 297-307.
Crossref
Crossref
Irene Worthington, Tamara Pringsheim, Marek J. Gawel, Jonathan Gladstone, Paul Cooper, Esma Dilli, Michel Aube, Elizabeth Leroux & Werner J. Becker. (2015) Pharmacological Acute Migraine Treatment Strategies: Choosing the Right Drug for a Specific Patient. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 40:S3, pages S33-S62.
Crossref
Crossref
Irene Worthington, Tamara Pringsheim, Marek J. Gawel, Jonathan Gladstone, Paul Cooper, Esma Dilli, Michel Aube, Elizabeth Leroux & Werner J. Becker. (2014) Pharmacological Acute Migraine Treatment Strategies: Choosing the Right Drug for a Specific Patient. The Canadian Journal of Neurological Sciences 40:S3, pages s33-s62.
Crossref
Crossref
Nils Erik Gilhus, Michael P. Barnes & Michael BraininS. Evers, J. Áfra, A. Frese, P. J. Goadsby, M. Linde, A. May & P. S. S´ndor. 2010. European Handbook of Neurological Management. European Handbook of Neurological Management
159
177
.
Ratnesh Jain, Swapna Nabar, Prajakta Dandekar & Vandana Patravale. (2010) Micellar Nanocarriers: Potential Nose-to-Brain Delivery of Zolmitriptan as Novel Migraine Therapy. Pharmaceutical Research 27:4, pages 655-664.
Crossref
Crossref
S. Evers, J. Áfra, A. Frese, P. J. Goadsby, M. Linde, A. May & P. S. Sándor. (2009) EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. European Journal of Neurology 16:9, pages 968-981.
Crossref
Crossref
F. Ebinger, P. Kropp, R. Pothmann, F. Heinen & S. Evers. (2009) Therapie idiopathischer Kopfschmerzen im Kindes- und JugendalterTreatment of idiopathic headache in childhood and adolescence. Monatsschrift Kinderheilkunde 157:6, pages 599-610.
Crossref
Crossref
Li-Chia Chen & Darren M. Ashcroft. (2007) Meta-Analysis of the Efficacy and Safety of Zolmitriptan in the Acute Treatment of Migraine. Headache: The Journal of Head and Face Pain 48:2, pages 236-247.
Crossref
Crossref
Andrew Dowson, Michael Bundy, Rebecca Salt & Shaun Kilminster. (2007) Patient Preference for Triptan Formulations: A Prospective Study With Zolmitriptan. Headache: The Journal of Head and Face Pain 47:8, pages 1144-1151.
Crossref
Crossref
S. Evers, J. Afra, A. Frese, P. J. Goadsby, M. Linde, A. May & P. S. Sandor. (2006) EFNS guideline on the drug treatment of migraine - report of an EFNS task force. European Journal of Neurology 13:6, pages 560-572.
Crossref
Crossref
S. Evers, J. Áfra, A. Frese, P. J. Goadsby, M. Linde, A. May & P. S. Sándor. 2006. European Handbook of Neurological Management. European Handbook of Neurological Management
159
176
.
J.C. Cuvellier, S. Joriot, S. Auvin & L. Vallée. (2005) Traitement médicamenteux de l’accès migraineux chez l’enfant. Archives de Pédiatrie 12:3, pages 316-325.
Crossref
Crossref
Lisa K Mannix & Julia A Files. (2005) The Use of Triptans in the Management of Menstrual Migraine. CNS Drugs 19:11, pages 951-972.
Crossref
Crossref
M. überall, H. Denecke & B. Kröner-Herwig. 2005. Schmerztherapie bei Kindern. Schmerztherapie bei Kindern
269
290
.
J Scholpp, R Schellenberg, B Moeckesch & N Banik. (2016) Early Treatment of a Migraine Attack while Pain is Still Mild Increases the Efficacy of Sumatriptan. Cephalalgia 24:11, pages 925-933.
Crossref
Crossref
H.C. Diener, S. Evers & A. Gendolla. (2004) The therapeutic profile of zolmitriptan in clinical practice. International Journal of Clinical Practice 58:8, pages 795-800.
Crossref
Crossref
Marcelo E. Bigal, Carlos A. Bordini, Ana L. Antoniazzi & Jos? G. Speciali. (2003) The triptan formulations: a critical evaluation. Arquivos de Neuro-Psiquiatria 61:2A, pages 313-320.
Crossref
Crossref
Dara Jamieson, F. Michael Cutrer, Jerome Goldstein, Jeffrey Dayno, X. Henry Hu & on behalf of the USMAP Investigator. (2003) Real-World Experiences in Migraine Therapy With Rizatriptan. Headache: The Journal of Head and Face Pain 43:3, pages 223-230.
Crossref
Crossref
Alan M Rapoport, Stewart J Tepper, Marcelo E Bigal & Fred D Sheftell. (2003) The Triptan Formulations. CNS Drugs 17:6, pages 431-447.
Crossref
Crossref
M. Überall, H. Denecke & B. Kröner-Herwig. 2003. Schmerztherapie bei Kindern. Schmerztherapie bei Kindern
315
340
.
MD Ferrari, PJ Goadsby, KI Roon & RB Lipton. (2016)
Triptans (Serotonin, 5-HT
1B/1D
Agonists) in Migraine: Detailed Results and Methods of A Meta-Analysis of 53 Trials
. Cephalalgia 22:8, pages 633-658.
Crossref
Crossref
Seymour Diamond & Richard Wenzel. (2002) Practical Approaches to Migraine Management. CNS Drugs 16:6, pages 385-403.
Crossref
Crossref
Fred D. Sheftell & Stewart J. Tepper. (2002) New Paradigms in the Recognition and Acute Treatment of Migraine. Headache: The Journal of Head and Face Pain 42:1, pages 58-69.
Crossref
Crossref
Fred D. Sheftell. (2014) Communicating the Right Therapy for the Right Patient at the Right Time: Acute Therapy. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 29:S2, pages S33-S39.
Crossref
Crossref
Stewart J. Tepper. (2001) SAFETY AND RATIONAL USE OF THE TRIPTANS. Medical Clinics of North America 85:4, pages 959-970.
Crossref
Crossref
Seymour Solomon, Benjamin Frishberg, X.Henry Hu, Leona Markson & Marc Berger. (2001) Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study. Clinical Therapeutics 23:6, pages 886-900.
Crossref
Crossref
K. Gruffyd‐Jones, B. Kies, A. Middleton, L. J. M. M. Mulder, Ø. Røsjø & D. S. Millson. (2001) Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double‐blind, international study. European Journal of Neurology 8:3, pages 237-245.
Crossref
Crossref
Frederick G. Freitag. (2001) Acute treatment of migraine and the role of triptans. Current Neurology and Neuroscience Reports 1:2, pages 125-132.
Crossref
Crossref
Marek J. Gawel, Irene Worthington & Anne Maggisano. (2017) Progress in Clinical Neurosciences A Systematic Review of the Use of Triptans in Acute Migraine. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 28:1, pages 30-41.
Crossref
Crossref
SL Linder & AJ Dowson. (2000) ZOLMITRIPTAN PROVIDES EFFECTIVE MIGRAINE RELIEF IN ADOLESCENTS. International Journal of Clinical Practice 54:7, pages 466-469.
Crossref
Crossref
Robert E. RyanJrJr, Seymour Diamond, Rose A. Giammarco, Sheena K. Aurora, Ronald C. Reed & Pamela E. Fletcher. (2000) Efficacy of Zolmitriptan at Early Time-Points for the Acute Treatment of Migraine and Treatment of Recurrence. CNS Drugs 13:3, pages 215-226.
Crossref
Crossref